Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D06LLJ
|
|||
| Former ID |
DNC002209
|
|||
| Drug Name |
ISIS 119283
|
|||
| Drug Type |
Antisense drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Company |
Isis Pharmaceuticals
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | STXBP4 messenger RNA (STXBP4 mRNA) | Target Info | . | [1] |
| Pathway Interaction Database | Validated transcriptional targets of deltaNp63 isoforms | |||
| Insulin-mediated glucose transport | ||||
| WikiPathways | Insulin Signaling | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | US patent application no. 6,503,756, Antisense modulation of syntaxin 4 interacting protein expression. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.